Messaging Strategies for Lung Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests different methods of communicating with individuals who might need lung cancer screening. It compares the effectiveness of messages sent through a patient portal and text reminders in encouraging screenings. The trial seeks to identify the best outreach methods for racial/ethnic minorities and rural residents. Suitable participants include those who have smoked for at least 20 years, are current smokers or quit within the last 15 years, and are connected to Atrium Health Wake Forest Baptist health network with a patient portal account or cell phone. As an unphased trial, this study offers a unique opportunity to enhance communication strategies for lung cancer screening.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that these messaging strategies are safe for participants?
Research has shown that digital tools like text messages and patient portal messages are generally safe for increasing cancer screening rates. Studies have found that text message reminders boost screening rates for various cancers, including lung cancer. Patients appreciate these reminders, which encourage attendance at screenings.
Patient portal messages also effectively prompt individuals to complete important health screenings, increasing participation without reported safety issues. Both text and portal messages have been used successfully in healthcare, yielding positive results without significant problems.
Overall, these digital communication methods are well-received and pose minimal risk to participants.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative communication strategies for lung cancer patients, aiming to improve patient engagement and care outcomes. Unlike traditional approaches that rely heavily on in-person consultations and standard care protocols, this trial examines the impact of digital messaging. The study compares different messaging techniques: a combination of patient portal messages with reminder texts, text messages with reminders, and solely portal messages. By focusing on how these digital tools can enhance communication and potentially lead to better adherence and outcomes, the trial could pave the way for more personalized and efficient patient care models.
What evidence suggests that this trial's messaging strategies could be effective for lung cancer?
This trial will compare different messaging strategies to increase lung cancer screening rates. Participants will be assigned to one of several arms: one group will receive patient portal messages followed by up to three reminder text messages, another group will receive only text messages with up to three reminders, and a third group will receive only portal messages without reminders. Research has shown that digital tools can help increase lung cancer screening rates. Specifically, sending messages through patient portals, along with reminder texts, has succeeded in encouraging more people to participate in cancer screenings. Studies have found that these methods can greatly improve both the quality of life and the likelihood of patients getting screened. While messages alone are helpful, they become more effective when paired with reminders. Text message reminders, in particular, have proven to boost screening rates by prompting people to take action. Overall, these strategies help remind and motivate individuals to complete important lung cancer screenings.12367
Who Is on the Research Team?
Brent Heideman, Jr., MD
Principal Investigator
Wake Forest Baptist Comprehensive Cancer Center
Are You a Good Fit for This Trial?
This trial is for people aged 50-77 who have smoked the equivalent of a pack a day for 20 years, are current smokers or quit within the last 15 years. They must be patients within the Atrium Health Wake Forest Baptist network with at least one recent primary care visit and have either a patient portal account or cellphone number on record.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive outreach through mPATH-Lung to increase lung cancer screening rates
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Portal message only
- Portal Message with Reminder Text Messages
- Text Message with Reminder Text Messages
Trial Overview
The study tests different methods of reaching out to lung cancer patients using technology: text messages with reminders, portal messages with reminders, and portal messages only. It aims to see which method is most effective in engaging diverse groups including minorities and rural residents.
How Is the Trial Designed?
4
Treatment groups
Experimental Treatment
Active Control
Portal message only with no reminder messages.
Text message only with up to 3 reminder text messages.
Patient portal message first followed by up to 3 reminder text messages.
Patients receive usual care.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Citations
Effectiveness of health communication intervention to ...
Abstract. Background: Many patients are unaware of the need to repeat lung cancer screening (LCS) annually despite shared decision-making.
Study Details | NCT07322367 | Learning Health System Trial
Primary Objective: Evaluate the real-world effectiveness of mPATH-Lung in increasing lung cancer ... Portal message only with no reminder messages ...
Effectiveness of symptom monitoring on electronic patient ...
The meta-analysis showed significant improvement in health-related quality of life (SMD = 2.44, P < 0.001) among patients with lung cancer.
Digital engagement and the efficacy of patient portal-based ...
This study aims to identify whether patient portal engagement and primary care visits affect the efficacy of patient portal-based screening or vaccine ...
5.
insideprecisionmedicine.com
insideprecisionmedicine.com/topics/oncology/digital-health-program-improves-lung-cancer-screening-uptake/Digital Health Program Improves Lung Cancer Screening ...
A digital intervention that interacts with patients directly can improve lung cancer screening rates compared with enhanced usual care.
Text Messaging Interventions on Cancer Screening Rates
Text messaging interventions appear to moderately increase screening rates for breast and cervical cancer and may have a small effect on colorectal cancer ...
Understanding Patient Perspectives on Digital Smoking ...
Our previously conducted pragmatic randomized trial to evaluate the effectiveness of digital PGHD approaches (ie, text message, portal-based ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.